📰 Amrep Co News
Page 2 - Amrep Co News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Amrep Co. Real-time updates on events, politics, business and more.
October 4, 2023
AMREP Co. (NYSE:AXR – Get Free Report) Director Robert Robotti purchased 1,672 shares of the stock in a transaction dated Thursday, September 28th. The shares were bought at an average price of $16.44 per share, for a total transaction of $27,487.68. Following the completion of the acquisition, the director now owns 288,177 shares in the […]
July 31, 2023
AMREP Co. (NYSE:AXR – Get Free Report) Director Robert Robotti acquired 1,752 shares of the company’s stock in a transaction on Monday, July 31st. The stock was acquired at an average cost of $16.52 per share, for a total transaction of $28,943.04. Following the completion of the purchase, the director now directly owns 286,505 shares […]
July 29, 2023
AMREP Co. (NYSE:AXR – Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $14.67 and traded as high as $18.60. AMREP shares last traded at $17.08, with a volume of 14,905 shares changing hands. Analyst Upgrades and Downgrades Separately, StockNews.com downgraded shares […]
June 21, 2023
AMREP Co. (NYSE:AXR – Get Rating) was the recipient of a significant decrease in short interest in May. As of May 31st, there was short interest totalling 15,600 shares, a decrease of 5.5% from the May 15th total of 16,500 shares. Based on an average daily trading volume, of 7,100 shares, the days-to-cover ratio is […]
May 31, 2023
AMREP Co. (NYSE:AXR – Get Rating) was the target of a large decrease in short interest in May. As of May 15th, there was short interest totalling 16,500 shares, a decrease of 5.7% from the April 30th total of 17,500 shares. Approximately 0.6% of the shares of the stock are short sold. Based on an […]
May 23, 2023
Analysts’ new coverage for Tuesday, May 23rd: StockNews.com started coverage on shares of Acorda Therapeutics (NASDAQ:ACOR). The firm issued a buy rating on the stock. StockNews.com began coverage on shares of Aspira Women’s Health (NYSE:AWH). The firm issued a sell rating on the stock. CL King began coverage on shares of Axonics (NASDAQ:AXNX). CL King […]
May 15, 2023
Analysts’ new coverage for Monday, May 15th: StockNews.com initiated coverage on shares of Acorda Therapeutics (NASDAQ:ACOR). The firm issued a buy rating on the stock. Citigroup Inc. initiated coverage on shares of AerCap (NYSE:AER). The firm issued a buy rating and a $71.00 price target on the stock. Citigroup Inc. initiated coverage on shares of […]
May 7, 2023
Stock Analysts’ new coverage for Sunday, May 7th: StockNews.com began coverage on shares of Acorda Therapeutics (NASDAQ:ACOR). They issued a buy rating on the stock. StockNews.com started coverage on shares of AMREP (NYSE:AXR). The firm issued a buy rating on the stock. StockNews.com initiated coverage on shares of BSQUARE (NASDAQ:BSQR). The firm issued a sell […]
April 30, 2023
AMREP Co. (NYSE:AXR – Get Rating) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 20,600 shares, an increase of 14.4% from the March 31st total of 18,000 shares. Approximately 0.7% of the shares of the company are short sold. Based on an […]
April 6, 2023
AMREP Co. (NYSE:AXR – Get Rating)’s stock price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $12.19 and traded as high as $15.26. AMREP shares last traded at $15.11, with a volume of 23,151 shares traded. Analyst Upgrades and Downgrades Separately, StockNews.com assumed coverage […]